Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-26

Clinical Trial Update: Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder [Phase 3]

View source ↗

Summary

A phase 3 trial evaluated aripiprazole for reducing tics in children and adolescents with chronic motor/vocal tic disorders or Tourette syndrome; results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Korea Otsuka Pharmaceutical Co., Ltd. | Conditions: Chronic Motor or Vocal Tic Disorder, Tourette's Disorder | Phase 3 | Status: COMPLETED | Results posted: 2013-07-26